Rui Ran

1.7k total citations
27 papers, 1.5k citations indexed

About

Rui Ran is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Rui Ran has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Biomaterials and 7 papers in Biomedical Engineering. Recurrent topics in Rui Ran's work include Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (13 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Rui Ran is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (13 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Rui Ran collaborates with scholars based in China, Australia and Netherlands. Rui Ran's co-authors include Chun‐Xia Zhao, Qianyu Zhang, Yue Hui, Anton P. J. Middelberg, Zhirong Zhang, Jie Tang, Haofei Wang, Yun Liu, Yayuan Liu and Huile Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Rui Ran

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Ran China 16 719 700 683 172 111 27 1.5k
Kairong Shi China 20 851 1.2× 657 0.9× 825 1.2× 141 0.8× 83 0.7× 25 1.4k
Sanyogitta Puri United Kingdom 14 726 1.0× 639 0.9× 734 1.1× 140 0.8× 109 1.0× 20 1.6k
Xinghai Li United States 23 775 1.1× 432 0.6× 629 0.9× 166 1.0× 81 0.7× 36 1.5k
Mami Murakami Canada 7 904 1.3× 713 1.0× 490 0.7× 191 1.1× 97 0.9× 8 1.4k
Émilie Allard-Vannier France 24 709 1.0× 480 0.7× 656 1.0× 234 1.4× 110 1.0× 45 1.5k
Sharon M. Sagnella Australia 27 786 1.1× 470 0.7× 774 1.1× 135 0.8× 118 1.1× 45 1.8k
Huaiwen Chen China 20 564 0.8× 437 0.6× 657 1.0× 222 1.3× 66 0.6× 31 1.2k
Sara Zalba Spain 17 520 0.7× 370 0.5× 604 0.9× 204 1.2× 82 0.7× 29 1.2k
David A. Eavarone United States 7 518 0.7× 420 0.6× 470 0.7× 93 0.5× 78 0.7× 10 988
Peiqi Zhao China 20 595 0.8× 668 1.0× 545 0.8× 123 0.7× 138 1.2× 30 1.3k

Countries citing papers authored by Rui Ran

Since Specialization
Citations

This map shows the geographic impact of Rui Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Ran more than expected).

Fields of papers citing papers by Rui Ran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Ran. The network helps show where Rui Ran may publish in the future.

Co-authorship network of co-authors of Rui Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Ran. A scholar is included among the top collaborators of Rui Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Ran. Rui Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Bing, Rui Ran, Ruud Verkerk, et al.. (2024). Advancements in balancing glucosinolate production in plants to deliver effective defense and promote human health. SHILAP Revista de lepidopterología. 2(2). 100040–100040. 5 indexed citations
2.
Yi, Yan, Hanfang Jiang, Ling Xu, et al.. (2020). [Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice].. PubMed. 52(2). 254–260. 7 indexed citations
3.
Ran, Rui, Haofei Wang, Yun Liu, et al.. (2018). Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting. European Journal of Pharmaceutics and Biopharmaceutics. 130. 1–10. 60 indexed citations
4.
Hui, Yue, David Wibowo, Yun Liu, et al.. (2018). Understanding the Effects of Nanocapsular Mechanical Property on Passive and Active Tumor Targeting. ACS Nano. 12(3). 2846–2857. 158 indexed citations
5.
Sun, Qi, Say Hwa Tan, Qiushui Chen, et al.. (2018). Microfluidic Formation of Coculture Tumor Spheroids with Stromal Cells As a Novel 3D Tumor Model for Drug Testing. ACS Biomaterials Science & Engineering. 4(12). 4425–4433. 83 indexed citations
6.
Wang, Haofei, Rui Ran, Yun Liu, et al.. (2018). Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation. ACS Nano. 12(11). 11600–11609. 130 indexed citations
7.
Ran, Rui, Qi Sun, Thejus Baby, et al.. (2017). Multiphase microfluidic synthesis of micro- and nanostructures for pharmaceutical applications. Chemical Engineering Science. 169. 78–96. 90 indexed citations
8.
Ran, Rui, Anton P. J. Middelberg, & Chun‐Xia Zhao. (2016). Microfluidic synthesis of multifunctional liposomes for tumour targeting. Colloids and Surfaces B Biointerfaces. 148. 402–410. 75 indexed citations
9.
Tang, Qilin, et al.. (2016). The Application of Chitosan and Its Derivatives as Nanosized Carriers for the Delivery of Chemical Drugs and Genes or Proteins. Current Drug Targets. 17(7). 811–816. 9 indexed citations
10.
Zhang, Qianyu, Jie Tang, Rui Ran, et al.. (2015). Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides. Drug Delivery. 23(4). 1163–1170. 15 indexed citations
11.
12.
Ran, Rui, Yayuan Liu, Huile Gao, et al.. (2014). PEGylated Hyaluronic Acid-Modified Liposomal Delivery System with Anti-γ-Glutamylcyclotransferase siRNA for Drug-Resistant MCF-7 Breast Cancer Therapy. Journal of Pharmaceutical Sciences. 104(2). 476–484. 51 indexed citations
13.
Liu, Yayuan, Rui Ran, Jiantao Chen, et al.. (2014). Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials. 35(17). 4835–4847. 210 indexed citations
14.
Ran, Rui, Yayuan Liu, Huile Gao, et al.. (2014). Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: A potential candidate for overcoming multi-drug resistance. International Journal of Pharmaceutics. 477(1-2). 590–600. 52 indexed citations
15.
Zhang, Qianyu, Rui Ran, Li Zhang, et al.. (2014). Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system. Journal of Controlled Release. 197. 208–218. 61 indexed citations
16.
Tang, Jie, Han Fu, Qifang Kuang, et al.. (2014). Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery. Journal of drug targeting. 22(4). 313–326. 23 indexed citations
17.
Yuan, Wenmin, Rui Kuai, Wei Cai, et al.. (2014). Increased Delivery of Doxorubicin Into Tumor Cells Using Extracellularly Activated TAT Functionalized Liposomes: <I>In</I> <I> Vitro</I> and <I>In</I> <I>Vivo</I> Study. Journal of Biomedical Nanotechnology. 10(8). 1563–1573. 13 indexed citations
18.
Ran, Rui, et al.. (2013). Enhanced tumor accumulation and cellular uptake of liposomes modified with ether-bond linked cholesterol derivatives.. PubMed. 68(8). 668–74. 1 indexed citations
19.
Zhang, Qianyu, Jie Tang, Ling Fu, et al.. (2013). A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Biomaterials. 34(32). 7980–7993. 150 indexed citations
20.
Ran, Rui, et al.. (1993). [Experimental study on intratumoral injection with hydroxyapatite bioceramics and adriamycin in implanted hepatoma in mice].. PubMed. 24(1). 45–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kairong Shi Breakdown of academic impact, for papers by Sanyogitta Puri Breakdown of academic impact, for papers by Xinghai Li Breakdown of academic impact, for papers by Mami Murakami Breakdown of academic impact, for papers by Émilie Allard-Vannier Breakdown of academic impact, for papers by Sharon M. Sagnella Breakdown of academic impact, for papers by Huaiwen Chen Breakdown of academic impact, for papers by Sara Zalba Breakdown of academic impact, for papers by David A. Eavarone Breakdown of academic impact, for papers by Peiqi Zhao
Rankless by CCL
2026